 |
PDBsum entry 1okx
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
1okx
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.21.36
- pancreatic elastase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of proteins, including elastin. Preferential cleavage: Ala-|-Xaa.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Chem Biol
10:997
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Binding structure of elastase inhibitor scyptolin A.
|
|
U.Matern,
C.Schleberger,
S.Jelakovic,
J.Weckesser,
G.E.Schulz.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Natural bioactive compounds are of general interest to pharmaceutical research
because they may be used as leads in drug development campaigns. Among them,
scyptolin A and B from Scytonema hofmanni PCC 7110 are known to inhibit porcine
pancreatic elastase, which in turn resembles the attractive drug target
neutrophil elastase. The crystal structure of scyptolin A as bound to pancreatic
elastase was solved at 2.8 A resolution. The inhibitor occupies the most
prominent subsites S1 through S4 of the elastase and prevents a hydrolytic
attack by covering the active center with its rigid ring structure. The observed
binding structure may help to design potent elastase inhibitors.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 2.
Figure 2. Stereo Views of Scyptolin A Binding to Porcine
Pancreatic Elastase(A) Ribbon plot of elastase with the initial
(F[o]-F[c]) electron density map of scyptolin A at a contour
level of 3 σ. The final model of scyptolin A is drawn into the
density. The side chains of the catalytic triad of elastase
are given for reference (pink).(B) Stereo view of scyptolin A
bound to elastase represented by its molecular surface. The
catalytic triad beneath the surface is shown; the putative
nucleophilic attack of the serine is indicated by a dashed red
line. The inhibitor with its rigid cyclic peptide structure sits
snugly in the active center pocket.
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Chem Biol
(2003,
10,
997-0)
copyright 2003.
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Liu,
and
K.S.Rein
(2010).
New peptides isolated from Lyngbya species: a review.
|
| |
Mar Drugs,
8,
1817-1837.
|
 |
|
|
|
|
 |
S.C.Stolze,
M.Meltzer,
M.Ehrmann,
and
M.Kaiser
(2010).
Solid phase total synthesis of the 3-amino-6-hydroxy-2-piperidone (Ahp) cyclodepsipeptide and protease inhibitor Symplocamide A.
|
| |
Chem Commun (Camb),
46,
8857-8859.
|
 |
|
|
|
|
 |
J.C.Kwan,
K.Taori,
V.J.Paul,
and
H.Luesch
(2009).
Lyngbyastatins 8-10, elastase inhibitors with cyclic depsipeptide scaffolds isolated from the marine cyanobacterium Lyngbya semiplena.
|
| |
Mar Drugs,
7,
528-538.
|
 |
|
|
|
|
 |
M.T.Sisay,
S.Hautmann,
C.Mehner,
G.M.König,
J.Bajorath,
and
M.Gütschow
(2009).
Inhibition of human leukocyte elastase by brunsvicamides a-C: cyanobacterial cyclic peptides.
|
| |
ChemMedChem,
4,
1425-1429.
|
 |
|
|
|
|
 |
A.Bubik,
B.Sedmak,
M.Novinec,
B.Lenarcic,
and
T.T.Lah
(2008).
Cytotoxic and peptidase inhibitory activities of selected non-hepatotoxic cyclic peptides from cyanobacteria.
|
| |
Biol Chem,
389,
1339-1346.
|
 |
|
|
|
|
 |
C.Mehner,
D.Müller,
S.Kehraus,
S.Hautmann,
M.Gütschow,
and
G.M.König
(2008).
New peptolides from the cyanobacterium Nostoc insulare as selective and potent inhibitors of human leukocyte elastase.
|
| |
Chembiochem,
9,
2692-2703.
|
 |
|
|
|
|
 |
S.Cadel-Six,
C.Dauga,
A.M.Castets,
R.Rippka,
C.Bouchier,
N.Tandeau de Marsac,
and
M.Welker
(2008).
Halogenase genes in nonribosomal peptide synthetase gene clusters of Microcystis (cyanobacteria): sporadic distribution and evolution.
|
| |
Mol Biol Evol,
25,
2031-2041.
|
 |
|
|
|
|
 |
M.Welker,
and
H.von Döhren
(2006).
Cyanobacterial peptides - nature's own combinatorial biosynthesis.
|
| |
FEMS Microbiol Rev,
30,
530-563.
|
 |
|
|
|
|
 |
O.Czarnecki,
M.Henning,
I.Lippert,
and
M.Welker
(2006).
Identification of peptide metabolites of Microcystis (Cyanobacteria) that inhibit trypsin-like activity in planktonic herbivorous Daphnia (Cladocera).
|
| |
Environ Microbiol,
8,
77-87.
|
 |
|
|
|
|
 |
T.Kinoshita,
A.Yamaguchi,
and
T.Tada
(2006).
Tris(hydroxymethyl)aminomethane induces conformational change and crystal-packing contraction of porcine pancreatic elastase.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
62,
623-626.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.W.Schüttelkopf,
and
D.M.van Aalten
(2004).
PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
1355-1363.
|
 |
|
|
|
|
 |
M.A.McDonough,
and
C.J.Schofield
(2003).
New structural insights into the inhibition of serine proteases by cyclic peptides from bacteria.
|
| |
Chem Biol,
10,
898-900.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |